World's Best Scientists 2026 revealed!

D-Index & Metrics

Microbiology

D-Index
68
Citations
16421
World Ranking
2163
National Ranking
903

Mark T. Heise publication distribution in Microbiology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Microbiology in 2026. The highlighted bar marks where Mark T. Heise sits on this spectrum.

55–64 publications: 8 scientists 65–74 publications: 29 scientists 75–84 publications: 55 scientists 85–94 publications: 112 scientists 95–104 publications: 137 scientists 105–114 publications: 190 scientists 115–124 publications: 235 scientists 125–134 publications: 234 scientists 135–144 publications: 288 scientists 145–154 publications: 264 scientists 155–164 publications: 264 scientists 165–174 publications: 253 scientists 175–184 publications: 276 scientists 185–194 publications: 190 scientists 195–204 publications: 233 scientists 205–214 publications: 207 scientists 215–224 publications: 198 scientists 225–234 publications: 155 scientists 235–244 publications: 161 scientists 245–254 publications: 160 scientists 255–264 publications: 146 scientists 265–274 publications: 139 scientists 275–284 publications: 148 scientists 285–294 publications: 115 scientists 295–304 publications: 96 scientists 305–314 publications: 88 scientists 315–324 publications: 106 scientists 325–334 publications: 65 scientists 335–344 publications: 76 scientists 345–354 publications: 64 scientists 355–364 publications: 62 scientists 365–374 publications: 65 scientists 375–384 publications: 61 scientists 385–394 publications: 34 scientists 395–404 publications: 44 scientists 405–414 publications: 36 scientists 415–424 publications: 35 scientists 425–434 publications: 29 scientists 435–444 publications: 33 scientists 445–454 publications: 34 scientists 455–464 publications: 25 scientists 465–474 publications: 26 scientists 475–484 publications: 20 scientists 485–494 publications: 19 scientists 495–504 publications: 16 scientists 505–514 publications: 17 scientists 515–524 publications: 23 scientists 525–534 publications: 14 scientists 535–544 publications: 14 scientists 545–554 publications: 18 scientists 555–564 publications: 12 scientists 565–574 publications: 7 scientists 575–584 publications: 9 scientists 585–594 publications: 9 scientists 595–604 publications: 9 scientists 605–614 publications: 7 scientists 615–624 publications: 9 scientists 625–634 publications: 7 scientists 635–644 publications: 4 scientists 645–654 publications: 5 scientists 655–664 publications: 6 scientists 665–674 publications: 7 scientists 675–678 publications: 3 scientists 679+ publications: 99 scientists
55 publications 679+

This scientist: 171 publications — 36th percentile

36% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 679 publications or more.

Mark T. Heise D-index placement in Microbiology in 2026

The chart shows the D-index (discipline H-index) distribution of Microbiology scientists ranked by Research.com in 2026. The highlighted bar marks where Mark T. Heise sits on this spectrum.

40 D-Index: 30 scientists 41 D-Index: 86 scientists 42 D-Index: 90 scientists 43 D-Index: 117 scientists 44 D-Index: 122 scientists 45 D-Index: 123 scientists 46 D-Index: 108 scientists 47 D-Index: 110 scientists 48 D-Index: 106 scientists 49 D-Index: 109 scientists 50 D-Index: 129 scientists 51 D-Index: 111 scientists 52 D-Index: 116 scientists 53 D-Index: 127 scientists 54 D-Index: 134 scientists 55 D-Index: 134 scientists 56 D-Index: 111 scientists 57 D-Index: 136 scientists 58 D-Index: 162 scientists 59 D-Index: 151 scientists 60 D-Index: 139 scientists 61 D-Index: 122 scientists 62 D-Index: 126 scientists 63 D-Index: 144 scientists 64 D-Index: 109 scientists 65 D-Index: 103 scientists 66 D-Index: 124 scientists 67 D-Index: 112 scientists 68 D-Index: 103 scientists 69 D-Index: 131 scientists 70 D-Index: 93 scientists 71 D-Index: 93 scientists 72 D-Index: 96 scientists 73 D-Index: 92 scientists 74 D-Index: 80 scientists 75 D-Index: 66 scientists 76 D-Index: 87 scientists 77 D-Index: 60 scientists 78 D-Index: 73 scientists 79 D-Index: 59 scientists 80 D-Index: 57 scientists 81 D-Index: 55 scientists 82 D-Index: 47 scientists 83 D-Index: 77 scientists 84 D-Index: 50 scientists 85 D-Index: 45 scientists 86 D-Index: 42 scientists 87 D-Index: 41 scientists 88 D-Index: 32 scientists 89 D-Index: 38 scientists 90 D-Index: 35 scientists 91 D-Index: 34 scientists 92 D-Index: 27 scientists 93 D-Index: 26 scientists 94 D-Index: 33 scientists 95 D-Index: 22 scientists 96 D-Index: 37 scientists 97 D-Index: 22 scientists 98 D-Index: 21 scientists 99 D-Index: 22 scientists 100 D-Index: 30 scientists 101 D-Index: 16 scientists 102 D-Index: 20 scientists 103 D-Index: 17 scientists 104 D-Index: 19 scientists 105 D-Index: 16 scientists 106 D-Index: 19 scientists 107 D-Index: 18 scientists 108 D-Index: 14 scientists 109 D-Index: 10 scientists 110 D-Index: 9 scientists 111 D-Index: 7 scientists 112 D-Index: 11 scientists 113 D-Index: 6 scientists 114 D-Index: 15 scientists 115 D-Index: 10 scientists 116 D-Index: 12 scientists 117 D-Index: 7 scientists 118 D-Index: 10 scientists 119 D-Index: 10 scientists 120 D-Index: 11 scientists 121 D-Index: 2 scientists 122 D-Index: 7 scientists 123 D-Index: 12 scientists 124 D-Index: 5 scientists 125 D-Index: 9 scientists 126 D-Index: 6 scientists 127+ D-Index: 95 scientists
40 D-Index 127+

This scientist: 68 D-Index — 62nd percentile

62% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 127 D-Index or more.

Overview

Mark T. Heise is affiliated with the University of North Carolina at Chapel Hill in the United States. Their research focuses primarily on the field of Medicine, with significant contributions to Infectious Diseases, Immunology, Public Health, Environmental and Occupational Health, Epidemiology, and Molecular Biology.

The scientist has authored numerous works related to infectious agents and immune responses, particularly focusing on viral infections and SARS-CoV-2. Key topics covered in their body of research include SARS-CoV-2 and COVID-19 research, mosquito-borne diseases and control, viral infections and vectors, interferon and immune responses, influenza virus research studies, COVID-19 clinical research studies, and animal virus infections studies.

They have published extensively in various scientific venues. Frequent publication outlets for their work include:

  • UNC Libraries
  • bioRxiv (Cold Spring Harbor Laboratory)
  • The Journal of Immunology
  • Journal of Medicinal Chemistry
  • PLoS Pathogens

Their collaborations have been with several frequent co-authors, including:

  • Ralph S. Baric
  • Martin T. Ferris
  • Sharon Taft-Benz
  • Nathaniel J. Moorman
  • Emily A. Madden

Recent notable publications by Mark T. Heise include:

  • β-d-N4-hydroxycytidine Inhibits SARS-CoV-2 Through Lethal Mutagenesis But Is Also Mutagenic To Mammalian Cells (2021, The Journal of Infectious Diseases)
  • Core mitochondrial genes are down-regulated during SARS-CoV-2 infection of rodent and human hosts (2023, Science Translational Medicine)
  • Content and Performance of the MiniMUGA Genotyping Array: A New Tool To Improve Rigor and Reproducibility in Mouse Research (2020, Genetics)
  • Vaccine formulations in clinical development for the prevention of severe acute respiratory syndrome coronavirus 2 infection (2020, Advanced Drug Delivery Reviews)
  • Novel virus-like nanoparticle vaccine effectively protects animal model from SARS-CoV-2 infection (2021, PLoS Pathogens)

Best Publications

  • Chikungunya: a re-emerging virus

    Felicity J Burt;Micheal S Rolph;Nestor E Rulli;Nestor E Rulli;Suresh Mahalingam

  • The genome architecture of the collaborative cross mouse genetic reference population

    Fuad A. Iraqi;Mustafa Mahajne;Yasser Salaymah;Hani Sandovski

  • NLRX1 is a regulator of mitochondrial antiviral immunity

    Chris B. Moore;Daniel T. Bergstralh;Joseph A. Duncan;Yu Lei

  • A Double-Inactivated Severe Acute Respiratory Syndrome Coronavirus Vaccine Provides Incomplete Protection in Mice and Induces Increased Eosinophilic Proinflammatory Pulmonary Response upon Challenge

    Meagan Bolles;Damon Deming;Kristin Michelle Long;Sudhakar Agnihothram

  • Complement Activation Contributes to Severe Acute Respiratory Syndrome Coronavirus Pathogenesis

    Lisa E. Gralinski;Timothy Patrick Sheahan;Thomas E. Morrison;Vineet D. Menachery;Vineet D. Menachery

  • Severe Acute Respiratory Syndrome Coronavirus ORF6 Antagonizes STAT1 Function by Sequestering Nuclear Import Factors on the Rough Endoplasmic Reticulum/Golgi Membrane

    Matthew Frieman;Boyd Yount;Mark Heise;Sarah A. Kopecky-Bromberg

  • A Mouse-Adapted SARS-Coronavirus Causes Disease and Mortality in BALB/c Mice

    Anjeanette Roberts;Damon Deming;Christopher D. Paddock;Aaron Cheng

  • A Gnotobiotic Mouse Model Demonstrates that Dietary Fiber Protects Against Colorectal Tumorigenesis in a Microbiota- and Butyrate-Dependent Manner

    Dallas R. Donohoe;Darcy Holley;Leonard B. Collins;Stephanie A. Montgomery

  • Toll-Like Receptor 3 Signaling via TRIF Contributes to a Protective Innate Immune Response to Severe Acute Respiratory Syndrome Coronavirus Infection

    Allison L. Totura;Alan Whitmore;Sudhakar Agnihothram;Alexandra Schäfer

  • Genetic analysis of complex traits in the emerging Collaborative Cross

    David L. Aylor;William Valdar;Wendy Foulds-Mathes;Ryan J. Buus

  • Host genetic diversity enables Ebola hemorrhagic fever pathogenesis and resistance

    Angela L. Rasmussen;Atsushi Okumura;Atsushi Okumura;Martin T Ferris;Richard Green

  • A Mouse Model of Chikungunya Virus–Induced Musculoskeletal Inflammatory Disease : Evidence of Arthritis, Tenosynovitis, Myositis, and Persistence

    Thomas E. Morrison;Lauren Oko;Stephanie A. Montgomery;Alan C. Whitmore

  • Vaccine Efficacy in Senescent Mice Challenged with Recombinant SARS-CoV Bearing Epidemic and Zoonotic Spike Variants

    Damon Deming;Timothy Sheahan;Mark Heise;Boyd Yount

  • Development of a Highly Protective Combination Monoclonal Antibody Therapy against Chikungunya Virus

    Pankaj Pal;Kimberly A. Dowd;James D. Brien;Melissa A. Edeling

  • Unique Signatures of Long Noncoding RNA Expression in Response to Virus Infection and Altered Innate Immune Signaling

    Xinxia Peng;Lisa Gralinski;Christopher D. Armour;Martin T Ferris

  • β-d-N4-hydroxycytidine Inhibits SARS-CoV-2 Through Lethal Mutagenesis But Is Also Mutagenic To Mammalian Cells.

    Shuntai Zhou;Collin S Hill;Sanjay Sarkar;Longping V Tse

  • SARS coronavirus and innate immunity.

    Matthew Frieman;Mark Heise;Ralph Baric

  • Characterization of Ross River Virus Tropism and Virus-Induced Inflammation in a Mouse Model of Viral Arthritis and Myositis

    Thomas E. Morrison;Alan C. Whitmore;Reed S. Shabman;Brett A. Lidbury

  • Dengue Virus Envelope Dimer Epitope Monoclonal Antibodies Isolated from Dengue Patients Are Protective against Zika Virus

    J. A. Swanstrom;Jessica Plante;K. S. Plante;E. F. Young

  • Modeling host genetic regulation of influenza pathogenesis in the collaborative cross.

    Martin T. Ferris;David L. Aylor;Daniel Bottomly;Alan C. Whitmore

  • Short Communication A Mouse Model of Chikungunya Virus-Induced Musculoskeletal Inflammatory Disease Evidence of Arthritis, Tenosynovitis, Myositis, and Persistence

    Thomas E. Morrison;Lauren Oko;Stephanie A. Montgomery;Alan C. Whitmore

Frequent Co-Authors

Ralph S. Baric
Ralph S. Baric University of North Carolina at Chapel Hill
Thomas E. Morrison
Thomas E. Morrison University of Colorado Anschutz Medical Campus
Lisa E. Gralinski
Lisa E. Gralinski University of North Carolina at Chapel Hill
Fernando Pardo-Manuel de Villena
Fernando Pardo-Manuel de Villena University of North Carolina at Chapel Hill
Vineet D. Menachery
Vineet D. Menachery The University of Texas Medical Branch at Galveston
Boyd Yount
Boyd Yount University of North Carolina at Chapel Hill
Daniel N. Streblow
Daniel N. Streblow Oregon Health & Science University
David W. Threadgill
David W. Threadgill Texas A&M University
Matthew B. Frieman
Matthew B. Frieman University of Maryland, Baltimore
Timothy P. Sheahan
Timothy P. Sheahan University of North Carolina at Chapel Hill

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Microbiology in the USA opens the door to various related online degrees and career pathways that can complement your scientific background. For those interested in healthcare, pursuing a path as a child life specialists salary often reflects the rewarding nature of supporting children through medical challenges, with roles that blend science and patient care.

Additionally, if you are looking to pivot or overcome past barriers, the article on degrees for felons highlights accessible online education options, enabling a fresh start in various fields including those linked to healthcare and science.

For professionals aiming to expand clinical expertise, becoming a functional nurse practitioner offers a growing career that integrates microbiological knowledge with patient-centered care practices, helping to optimize health outcomes through functional medicine.

Finally, the evolving healthcare industry also values administrative skills, where a certified professional coder plays a critical role in managing medical data and billing, making it a practical and in-demand career option linked to the broader medical field.

Best Scientists Citing Mark T. Heise

Trending Scientists

Recently Published Articles